Neuropathy and vasculopathy in colonic strictures from children with cystic fibrosis

Journal of Pediatric Surgery

Volumn 31, Issue 7, 1996, Pages 945-950

  Collins, Margaret H ^a,b   Azzarelli, Biagio ^a   West, Karen W ^a   Chong, Sonny K F ^a   Maguiness, Karen M ^a   Stevens, John C ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

colonic stricture; Cystic fibrosis; neuropathy; pancreatic enzyme supplement; vasculopathy

Indexed keywords

ACETYLCHOLINESTERASE; PANCREAS ENZYME; TYROSINE 3 MONOOXYGENASE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; CATECHOLAMINE RELEASE; CHILD; CLINICAL ARTICLE; COLON OBSTRUCTION; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG MEGADOSE; ENZYME REPLACEMENT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERPLASIA; INFANT; MALE; MYENTERIC PLEXUS; NEUROPATHY; PRIORITY JOURNAL; VASCULAR DISEASE;

EID: 0029979817     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3468(96)90418-2     Document Type: Article

References (32)

1. Dahms BB: The gastrointestinal tract, in Stocker JT, Dehner LP: Pediatric Pathology. Philadelphia, PA, Lippincott, 1992, p 673
2. Gross K, Desanto A, Grosfeld JL, et al: Intraabdominal complications of cystic fibrosis. J Pediatr Surg 20:431-435, 1985
3. Lloyd-Still JD: Crohn's disease and cystic fibrosis. Dig Dis Sci 39:880-885, 1994
4. Neglia JP, Fitzsimmons SC, Maissonneuve P, et al: The risk of cancer among patients with cystic fibrosis. N Engl J Med 332:494-499, 1995
5. Smyth RS, vanVelzen D, Smyth AR, et al: Strictures of ascending colon in cystic fibrosis and high strength pancreatic enzymes. Lancet 343:85-86, 1994
6. Oades PJ, Bush A, Ong PS, et al: Letter to the editor. Lancet 343:109, 1994
7. Campbell CA, Forrest J, Musgrove C: Letter to the editor. Lancet 343:109-110, 1994
8. Mahoney MJ, Corcoran M: Letter to the editor. Lancet 343:599-600, 1994
9. Briars GL, Griffiths DM, Moore IE, et al: Letter to the editor. Lancet 343:600, 1994
10. Knabe N, Zak M, Hansen A, et al: Extensive pathological changes of the colon in cystic fibrosis and high-strength pancreatic enzymes. Lancet 343:1230, 1994
11. Pettei MH, Leonidas JC, Levine JJ, et al: Pancolonic disease in cystic fibrosis and high-dose pancreatic enzyme therapy. J Pediatr 125:587-589, 1994
12. Rogers B, Prestridge, Pritchard M, et al: Diffuse fibrosis of the colon complicating cystic fibrosis. Pediatr Pathol 15:343, 1994 (abstr)
13. MacSweeney EJ, Oades PJ, Buchdahl R, et al: Relation of thickening of colon wall to pancreatic-enzyme treatment in cystic fibrosis. Lancet 345:752-756, 1995
14. Green MR, Southern KW, Wolfe SP, et al: Colonic strictures in cystic fibrosis. Arch Dis Child 72:191, 1995
15. Stevens J, Chong S, West K, et al: Colonic strictures in cystic fibrosis patients on very high dose pancreatic enzyme supplementation. Pediatr Pulmonol 810:275, 1994 (abstr)
16. Zerin JM, Kuhn-Fulton J, White SJ, et al: Colonic strictures in children with cystic fibrosis. Radiology 194:223-226, 1995
17. Munakata K, Morita K, Okabe I, et al: Clinical and histologic studies of neuronal intestinal dysplasia. J Pediatr Surg 20:231-235, 1985
18. Schofield De, Yunis EJ: Intestinal neuronal dysplasia. J Pediatr Gastroenterol Nutr 12:182-189, 1991
19. Sharli AF, Meier-Ruge W: Localized and disseminated forms of neuronal intestinal dysplasia mimicking Hirschsprung's disease. J Pediatr Surg 16:164-170, 1981
20. Burke AP, Sobin LH, Virmani R: Localized vasculitis of the gastrointestinal tract. Am J Surg Pathol 19:338-349, 1995
21. Flaherty MJ, Lie JT, Haggitt RC: Mesenteric inflammatory veno-occlusive disease. Am J Surg Pathol 18:779-784, 1994
22. Bailey J, John K: Cytochemistry and immunochemistry, in Rodak B (ed): Diagnostic Hematology. Philadelphia, PA, Saunders, 1995, pp 307-322
23. El-Badawi A, Schenk EA: Histochemical methods for separate consecutive and simultaneous demonstration of acetylcholinesterase and norepinephrine in cyrostat section. J Histochem Cytochem 15:580-588, 1967
24. Qualman SJ, Murray R: Aganglionosis and related disorders. Hum Pathol 25:1141-1149, 1994
25. Beker LT, Fink RJ, Shamsa FH, et al: Comparison of weight-based dosages of enteric-coated microtablet enzyme preparations in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 19:191-197, 1994
26. Brady MS, Richard K, Pao-Lo Y, et al: Effectiveness and safety of small vs large doses of enteric coated pancreatic enzymes in reducing steatorrhea in children with cystic fibrosis. a prospective randomized study. Pediatr Pulmonol 10:79-85, 1991
27. Strobach RS, Ross AH, Markin RS, et al: Neural patterns in inflammatory bowel disease. An immunohistochemical survey. Mod Pathol 3:488-493, 1990
28. Yunis EJ, Schofield DE: Intestinal neuronal dysplasia in a case of sigmoid stenosis. Pediatr Pathol 12:275-280, 1992
29. Sacher P, Briner J, Hanimann B: Is neuronal intestinal dysplasia (NID) a primary disease or a secondary phenomenon? Eur J Pediatr Surg 3:228-230, 1993
30. Kapur R: Contemporary approaches toward understanding the pathogenesis of Hirschsprung's disease. Pediatr Pathol 13:83-100, 1993
31. Puffenberger EG, Hosoda K, Washington SS, et al: A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell 79:1257-1266, 1994
32. Cystic fibrosis genotype-phenotype consortium. Correlation between genotype and phenotype in patients with cystic fibrosis. N Engl J Med 329:1308-1313, 1993